At the moment, risk stratification in Hypertrophic Cardiomyopathy relies on the application of clinical scores which have been shown to have only a moderate discriminative capacity in predicting sudden cardiac death and/or arrhythmic events. Cardiac magnetic resonance can estimate the amount of myocardial fibrosis which is thought to constitute the substrate for life-threatening ventricular arrhythmias. This CME will help to understand the role of cardiac magnetic resonance in improving risk stratification of Hypertrophic Cardiomyopathy. After this activity learners will understand the capability of cardiac magnetic resonance in detecting myocardial fibrosis, correctly estimate the amount of late gadolinium enhancement, and understand how cardiac magnetic resonance can improve risk stratification in patients with Hypertrophic Cardiomyopathy.
Credit Designation Statement
Instructions for Claiming CME
Disclosure of Commercial Support
July 01, 2019
Accreditation Council For Continuing Medical Education
Total General Hours: 1.00
SCMR Member Price:$0.00